{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:03:59Z","timestamp":1792065839560,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH R01 DK122332"],"award-info":[{"award-number":["NIH R01 DK122332"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH R01 DK122332"],"award-info":[{"award-number":["NIH R01 DK122332"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH R01 DK122332"],"award-info":[{"award-number":["NIH R01 DK122332"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH R01 DK122332"],"award-info":[{"award-number":["NIH R01 DK122332"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH R01 DK122332"],"award-info":[{"award-number":["NIH R01 DK122332"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH R01 DK122332"],"award-info":[{"award-number":["NIH R01 DK122332"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIH R01 DK122332"],"award-info":[{"award-number":["NIH R01 DK122332"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Diabetic nephropathy (DN) is a serious complicating factor in human type 2 diabetes mellitus\u00a0(T2DM), and it commonly results in end-stage renal disease (ESRD) that requires kidney dialysis. Here, we report that the \u03b17 nicotinic acetylcholine receptor (\u03b17nAChR) agonist GTS-21 exerts a novel anti-inflammatory action to ameliorate DN, as studied using an inbred strain of Lepr\n                    <jats:sup>db\/db<\/jats:sup>\n                    mice in which hyperglycemia and obesity co-exist owing to defective leptin receptor (Lepr) signaling. For this analysis, GTS-21 was administered to 10\u201312\u00a0week-old male and female mice as a 4\u00a0mg\/kg intraperitoneal injection, twice-a-day, for 8\u00a0weeks. Kidney function and injury owing to DN were monitored by determination of plasma levels of BUN, creatinine, KIM-1 and NGAL. Histologic analysis of glomerular hypertrophy and mesangial matrix expansion were also used to assess DN in these mice. Concurrently, renal inflammation was assessed by measuring IL-6 and HMGB1, while also quantifying renal cell apoptosis, and apoptotic signaling pathways. We found that Lepr\n                    <jats:sup>db\/db<\/jats:sup>\n                    mice exhibited increased markers of BUN, creatinine, NGAL, KIM-1, IL-6, cytochrome C, and HMGB-1. These abnormalities were also accompanied by histologic kidney injury (mesangial matrix expansion and apoptosis). Remarkably, all such pathologies were significantly reduced by GTS-21. Collectively, our results provide new evidence that the \u03b17nAChR agonist GTS-21 has the ability to attenuate diabetes-induced kidney injury. Additional studies are warranted to further investigate the involvement of the vagal cholinergic anti-inflammatory reflex pathway (CAP) in ameliorating diabetic nephropathy.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-27015-y","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T06:09:28Z","timestamp":1672034968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["GTS-21, a selective alpha7 nicotinic acetylcholine receptor agonist, ameliorates diabetic nephropathy in Leprdb\/db mice"],"prefix":"10.1038","volume":"12","author":[{"given":"Qinghe","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napat","family":"Pruekprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"key":"27015_CR1","doi-asserted-by":"publisher","first-page":"e012729","DOI":"10.1161\/JAHA.119.012729","volume":"8","author":"E Hackler 3rd","year":"2019","unstructured":"Hackler, E. 3rd. et al. Racial differences in cardiovascular biomarkers in the general population. J. Am. Heart Assoc. 8, e012729. https:\/\/doi.org\/10.1161\/JAHA.119.012729 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"27015_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12967-019-2016-y","volume":"17","author":"G Wang","year":"2019","unstructured":"Wang, G. et al. The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases. J. Transl. Med. 17, 264. https:\/\/doi.org\/10.1186\/s12967-019-2016-y (2019).","journal-title":"J. Transl. Med."},{"key":"27015_CR3","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic, R. Z., Rooney, M. T. & Tuttle, K. R. Diabetic kidney disease: Challenges, progress, and possibilities. Clin. J. Am. Soc. Nephrol. 12, 2032\u20132045. https:\/\/doi.org\/10.2215\/CJN.11491116 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"27015_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s11255-016-1488-4","volume":"49","author":"K Turkmen","year":"2017","unstructured":"Turkmen, K. Inflammation, oxidative stress, apoptosis, and autophagy in diabetes mellitus and diabetic kidney disease: The Four Horsemen of the Apocalypse. Int. Urol. Nephrol. 49, 837\u2013844. https:\/\/doi.org\/10.1007\/s11255-016-1488-4 (2017).","journal-title":"Int. Urol. Nephrol."},{"key":"27015_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1681\/ASN.2004080648","volume":"16","author":"MD Breyer","year":"2005","unstructured":"Breyer, M. D. et al. Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 16, 27\u201345. https:\/\/doi.org\/10.1681\/ASN.2004080648 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"27015_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00467-011-1773-5","volume":"26","author":"A Wasilewska","year":"2011","unstructured":"Wasilewska, A., Taranta-Janusz, K., Debek, W., Zoch-Zwierz, W. & Kuroczycka-Saniutycz, E. KIM-1 and NGAL: New markers of obstructive nephropathy. Pediatr. Nephrol. 26, 579\u2013586. https:\/\/doi.org\/10.1007\/s00467-011-1773-5 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"27015_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.ackd.2008.04.003","volume":"15","author":"CL Edelstein","year":"2008","unstructured":"Edelstein, C. L. Biomarkers of acute kidney injury. Adv. Chronic Kidney Dis. 15, 222\u2013234. https:\/\/doi.org\/10.1053\/j.ackd.2008.04.003 (2008).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"27015_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14693","author":"Q Meng","year":"2022","unstructured":"Meng, Q. et al. The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 engages the glucagon-like peptide-1 incretin hormone axis to lower levels of blood glucose in db\/db mice. Diabetes Obes. Metab. https:\/\/doi.org\/10.1111\/dom.14693 (2022).","journal-title":"Diabetes Obes. Metab."},{"key":"27015_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/MNH.0b013e3283451901","volume":"20","author":"CE Alpers","year":"2011","unstructured":"Alpers, C. E. & Hudkins, K. L. Mouse models of diabetic nephropathy. Curr. Opin. Nephrol. Hypertens. 20, 278\u2013284. https:\/\/doi.org\/10.1097\/MNH.0b013e3283451901 (2011).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"27015_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11154-020-09584-3","volume":"21","author":"H Xie","year":"2020","unstructured":"Xie, H. et al. Therapeutic potential of alpha7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation. Rev. Endocr. Metab. Disord. 21, 431\u2013447. https:\/\/doi.org\/10.1007\/s11154-020-09584-3 (2020).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"27015_CR11","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1172\/JCI86826","volume":"126","author":"SJ Atkinson","year":"2016","unstructured":"Atkinson, S. J. A wandering path toward prevention for acute kidney injury. J. Clin. Invest. 126, 1640\u20131642. https:\/\/doi.org\/10.1172\/JCI86826 (2016).","journal-title":"J. Clin. Invest."},{"key":"27015_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1073\/pnas.2021758118","volume":"118","author":"S Tanaka","year":"2021","unstructured":"Tanaka, S. et al. Vagus nerve stimulation activates two distinct neuroimmune circuits converging in the spleen to protect mice from kidney injury. Proc. Natl. Acad. Sci. USA 118, 12. https:\/\/doi.org\/10.1073\/pnas.2021758118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"27015_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1530\/JOE-10-0340","volume":"209","author":"Y Lin","year":"2011","unstructured":"Lin, Y. & Sun, Z. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes. J. Endocrinol. 209, 185\u2013191. https:\/\/doi.org\/10.1530\/JOE-10-0340 (2011).","journal-title":"J. Endocrinol."},{"key":"27015_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s0898-6568(01)00271-6","volume":"14","author":"KM Nicholson","year":"2002","unstructured":"Nicholson, K. M. & Anderson, N. G. The protein kinase B\/Akt signalling pathway in human malignancy. Cell Signal 14, 381\u2013395. https:\/\/doi.org\/10.1016\/s0898-6568(01)00271-6 (2002).","journal-title":"Cell Signal"},{"key":"27015_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fcell.2016.00091","volume":"4","author":"J Segales","year":"2016","unstructured":"Segales, J., Perdiguero, E. & Munoz-Canoves, P. Regulation of muscle stem cell functions: A Focus on the p38 MAPK signaling pathway. Fron.t Cell Dev. Biol. 4, 91. https:\/\/doi.org\/10.3389\/fcell.2016.00091 (2016).","journal-title":"Fron.t Cell Dev. Biol."},{"key":"27015_CR16","first-page":"45","volume":"11","author":"OO Oguntibeju","year":"2019","unstructured":"Oguntibeju, O. O. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int. J. Physiol. Pathophysiol. Pharmacol. 11, 45\u201363 (2019).","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"27015_CR17","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco, F. & Brownlee, M. Oxidative stress and diabetic complications. Circ. Res. 107, 1058\u20131070. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.223545 (2010).","journal-title":"Circ. Res."},{"key":"27015_CR18","doi-asserted-by":"publisher","first-page":"e35361","DOI":"10.1371\/journal.pone.0035361","volume":"7","author":"PK Chatterjee","year":"2012","unstructured":"Chatterjee, P. K. et al. Nicotinic acetylcholine receptor agonists attenuate septic acute kidney injury in mice by suppressing inflammation and proteasome activity. PLoS ONE 7, e35361. https:\/\/doi.org\/10.1371\/journal.pone.0035361 (2012).","journal-title":"PLoS ONE"},{"key":"27015_CR19","doi-asserted-by":"publisher","first-page":"e0188797","DOI":"10.1371\/journal.pone.0188797","volume":"12","author":"PK Chatterjee","year":"2017","unstructured":"Chatterjee, P. K. et al. Activation of the cholinergic anti-inflammatory pathway by GTS-21 attenuates cisplatin-induced acute kidney injury in mice. PLoS ONE 12, e0188797. https:\/\/doi.org\/10.1371\/journal.pone.0188797 (2017).","journal-title":"PLoS ONE"},{"key":"27015_CR20","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1093\/ndt\/gfaa200","volume":"35","author":"M Hilderman","year":"2020","unstructured":"Hilderman, M. & Bruchfeld, A. The cholinergic anti-inflammatory pathway in chronic kidney disease-review and vagus nerve stimulation clinical pilot study. Nephrol. Dial. Transplant. 35, 1840\u20131852. https:\/\/doi.org\/10.1093\/ndt\/gfaa200 (2020).","journal-title":"Nephrol. Dial. Transplant."},{"key":"27015_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000500920","volume":"44","author":"J Jarczyk","year":"2019","unstructured":"Jarczyk, J., Yard, B. A. & Hoeger, S. The cholinergic anti-inflammatory pathway as a conceptual framework to treat inflammation-mediated renal injury. Kidney Blood Press Res. 44, 435\u2013448. https:\/\/doi.org\/10.1159\/000500920 (2019).","journal-title":"Kidney Blood Press Res."},{"key":"27015_CR22","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1210\/en.2018-00433","volume":"159","author":"D Wang","year":"2018","unstructured":"Wang, D. et al. alpha7 nicotinic acetylcholine receptor regulates the function and viability of L cells. Endocrinology 159, 3132\u20133142. https:\/\/doi.org\/10.1210\/en.2018-00433 (2018).","journal-title":"Endocrinology"},{"key":"27015_CR23","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s10495-009-0359-1","volume":"14","author":"FA Wagener","year":"2009","unstructured":"Wagener, F. A., Dekker, D., Berden, J. H., Scharstuhl, A. & van der Vlag, J. The role of reactive oxygen species in apoptosis of the diabetic kidney. Apoptosis 14, 1451\u20131458. https:\/\/doi.org\/10.1007\/s10495-009-0359-1 (2009).","journal-title":"Apoptosis"},{"key":"27015_CR24","doi-asserted-by":"publisher","first-page":"536213","DOI":"10.3389\/fendo.2020.536213","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Acute hyperglycemia may induce renal tubular injury through mitophagy inhibition. Front. Endocrinol. 11, 536213. https:\/\/doi.org\/10.3389\/fendo.2020.536213 (2020).","journal-title":"Front. Endocrinol."},{"key":"27015_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4239\/wjd.v4.i2.27","volume":"4","author":"SL Habib","year":"2013","unstructured":"Habib, S. L. Diabetes and renal tubular cell apoptosis. World J. Diabetes 4, 27\u201330. https:\/\/doi.org\/10.4239\/wjd.v4.i2.27 (2013).","journal-title":"World J. Diabetes"},{"key":"27015_CR26","doi-asserted-by":"publisher","first-page":"1875870","DOI":"10.1155\/2018\/1875870","volume":"2018","author":"S Sifuentes-Franco","year":"2018","unstructured":"Sifuentes-Franco, S., Padilla-Tejeda, D. E., Carrillo-Ibarra, S. & Miranda-Diaz, A. G. Oxidative stress, apoptosis, and mitochondrial function in diabetic nephropathy. Int. J. Endocrinol. 2018, 1875870. https:\/\/doi.org\/10.1155\/2018\/1875870 (2018).","journal-title":"Int. J. Endocrinol."},{"key":"27015_CR27","doi-asserted-by":"publisher","first-page":"101247","DOI":"10.1016\/j.bbrep.2022.101247","volume":"30","author":"J Lee","year":"2022","unstructured":"Lee, J. et al. Natural COA water inhibits mitochondrial ROS-mediated apoptosis through Plk3 downregulation under STZ diabetic stress in pancreatic beta-cell lines. Biochem. Biophys. Rep. 30, 101247. https:\/\/doi.org\/10.1016\/j.bbrep.2022.101247 (2022).","journal-title":"Biochem. Biophys. Rep."},{"key":"27015_CR28","doi-asserted-by":"publisher","first-page":"e107220","DOI":"10.1371\/journal.pone.0107220","volume":"9","author":"PB Pal","year":"2014","unstructured":"Pal, P. B., Sinha, K. & Sil, P. C. Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFalpha related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats. PLoS ONE 9, e107220. https:\/\/doi.org\/10.1371\/journal.pone.0107220 (2014).","journal-title":"PLoS ONE"},{"key":"27015_CR29","doi-asserted-by":"publisher","first-page":"e108397","DOI":"10.1371\/journal.pone.0108397","volume":"9","author":"MC Maldifassi","year":"2014","unstructured":"Maldifassi, M. C. et al. A new IRAK-M-mediated mechanism implicated in the anti-inflammatory effect of nicotine via alpha7 nicotinic receptors in human macrophages. PLoS ONE 9, e108397. https:\/\/doi.org\/10.1371\/journal.pone.0108397 (2014).","journal-title":"PLoS ONE"},{"key":"27015_CR30","doi-asserted-by":"publisher","first-page":"696542","DOI":"10.3389\/fcell.2021.696542","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Signaling pathways involved in diabetic renal fibrosis. Front. Cell Dev. Biol. 9, 696542. https:\/\/doi.org\/10.3389\/fcell.2021.696542 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"27015_CR31","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3892\/etm.2018.7014","volume":"17","author":"Q Lu","year":"2019","unstructured":"Lu, Q. et al. ROS induces epithelial-mesenchymal transition via the TGF-beta1\/PI3K\/Akt\/mTOR pathway in diabetic nephropathy. Exp. Ther. Med. 17, 835\u2013846. https:\/\/doi.org\/10.3892\/etm.2018.7014 (2019).","journal-title":"Exp. Ther. Med."},{"key":"27015_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0061-x","volume":"50","author":"H Kim","year":"2018","unstructured":"Kim, H. et al. The proximal tubular alpha7 nicotinic acetylcholine receptor attenuates ischemic acute kidney injury through Akt\/PKC signaling-mediated HO-1 induction. Exp. Mol. Med. 50, 1\u201317. https:\/\/doi.org\/10.1038\/s12276-018-0061-x (2018).","journal-title":"Exp. Mol. Med."},{"key":"27015_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00125-008-1215-5","volume":"52","author":"AK Lim","year":"2009","unstructured":"Lim, A. K. et al. Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db\/db mice. Diabetologia 52, 347\u2013358. https:\/\/doi.org\/10.1007\/s00125-008-1215-5 (2009).","journal-title":"Diabetologia"},{"key":"27015_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrneph.2017.142","volume":"14","author":"K Azushima","year":"2018","unstructured":"Azushima, K., Gurley, S. B. & Coffman, T. M. Modelling diabetic nephropathy in mice. Nat. Rev. Nephrol. 14, 48\u201356. https:\/\/doi.org\/10.1038\/nrneph.2017.142 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"27015_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4939-7163-3_14","volume":"1639","author":"DA Fu","year":"2017","unstructured":"Fu, D. A. & Campbell-Thompson, M. Periodic acid-Schiff staining with diastase. Methods Mol. Biol. 1639, 145\u2013149. https:\/\/doi.org\/10.1007\/978-1-4939-7163-3_14 (2017).","journal-title":"Methods Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27015-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T06:18:23Z","timestamp":1672035503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27015-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["27015"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-27015-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2184341\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,26]]},"assertion":[{"value":"19 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22360"}}